The White house has identified five promising research projects for the production of vaccines against coronavirus infection COVID-19 for further support. It is reported by The New York Times.
The publication notes that the decision is a step towards fulfilling the promise of the White house on a large-scale immunization of Americans until the end of 2020.
Clarifies that among the projects that will receive financial support for further development, named development companies Moderna, AstraZeneca, Pfizer, Johnson & Johnson and Merck & Co.
In addition to additional funding, manufacturers will receive assistance in clinical trials and logistical support.
According to the publication, officially about the decision the White house will announce later.
Director of the National Institute of allergic and infectious diseases of the United States Anthony Fauci alluded to the upcoming presentation on Tuesday. He declared that the Washington administration hopes to develop a vaccine by January 2021.
Special medications from COVID-19 does not exist now in this disease is only symptomatic treatment. The world health organization notedthat a number of medicines can contribute to improved well-being and relief of symptoms COVID-19, but there is no evidence that any drug to prevent or treat the disease.
Who believe that the coronavirus would pose a serious threat, until they invent a vaccine. According to the head of the European Agency of medicines Marco Kavaleri, in the best case, the vaccine will be ready next year.